ENDO: Significant Decrease in Physical Activity Seen After GLP-1 Receptor Agonist Initiation
WEDNESDAY, June 17, 2026-- Adults with obesity initiating glucagon-like peptide-1 receptor agonist (GLP-1RA) medications have a significant decrease in their physical activity, according to a study presented at ENDO 2026, the annual meeting of the...
Read more »